Trials / Conditions / HIV Associated Neurocognitive Disorder
HIV Associated Neurocognitive Disorder
6 registered clinical trials studyying HIV Associated Neurocognitive Disorder — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy NCT05586581 | Yale University | Phase 1 / Phase 2 |
| Completed | Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning NCT02308332 | UMC Utrecht | Phase 4 |
| Completed | Advanced Neuroimaging Evaluation of CNS Changes Associated With Efavirenz Therapy Switch to an Raltegravir-bas NCT01978743 | Massachusetts General Hospital | N/A |
| Completed | Observational Study of HIV-associated Neurocognitive Disorder NCT01966094 | Emory University | — |
| Completed | HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Th NCT04266002 | Hôpital Franco-Britannique-Fondation Cognacq-Jay | N/A |
| Completed | Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder NCT01354314 | Johns Hopkins University | Phase 1 / Phase 2 |